share_log

綠葉製藥:自願性公告 - 創新藥蘆比替定在中國澳門獲批上市,用於治療復發性小細胞肺癌

LUYE PHARMA: VOLUNTARY ANNOUNCEMENT - INNOVATIVE DRUG LURBINECTEDIN APPROVED FOR THE TREATMENT OF RELAPSED SMALL CELL LUNG CANCER IN MACAO, CHINA

香港交易所 ·  Dec 3, 2023 23:03
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more